CPhI Show Daily Podcast Series - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Show Daily Podcast Series


rss itunes google yahoo

Click an icon above to automatically deliver podcasts to your iTunes or rich media player

CPhI Show Daily Podcast Series
line
BASF- Dr. Bernhard Fussnegger
Dr Bernhard Fussnegger is responsible for all technical questions regarding Povidone and Crospovidone at the unit Global Marketing for Pharmaceutical Ingredients and Service. With over 10 years experience in the pharmaceutical industry, Dr Fussnegger shares his insights into the multi-talented excipients, Povidone and Crospovidone, and addresses the key challenge of reducing peroxide levels with a cutting-edge solution.
line
Hameln- Dr. Olaf Schrake
Dr. Olaf Schrake discusses the wider range of services that hameln pharma can offer with its close working relationship with sister company Hameln rds. Going well beyond actual contract manufacturing, hameln pharma can offer strategic consultation concerning product portfolios or entire product developments through pre-clinical and clinical studies to a comprehensive approval service. Dr. Schrake also outlines hameln pharma’s philosophy of Operational Excellence.
line
Roquette- Sophie Chesnoy
One of Roquette’s focuses at this year’s CPhI is taste-masking solutions, in particular, Kleptose Linecaps. Sophie Chesnoy introduces a new addition to the Kleptose range: Kleptose Linecaps, which are derived from a natural source and can be used for the solubilisation of poorly soluble drugs in addition to taste masking. Roquette will also be showcasing a state-of-the-art compression simulator and E-tabletting concept for studying and optimising tablet manufacture from drug development through industrial scale-up to production.
line
Valsynthese- Mr. Helmut Zimmermann
Valsynthese is a custom manufacturing organisation concentrating on hazardous and high energetic chemistry. Mr. Zimmermann introduces Valsynthese’s new capabilities in phosgenation, further expanding their tool-box of core competencies in highly energetic reactions. Mr. Zimmerman also delivers quality system updates as well as future plans for compliance beyond approval as API manufacturers in Europe, Asia, South America and Japan. Reducing environmental impact through investment in new recycling facilities is also discussed.
line
PharmTech podcasts are developed and produced by Phamaceutical Technology, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here